New surface radiolabeling schemes of super paramagnetic iron oxide nanoparticles (SPIONs) for biodistribution studies.

Nanomaterial based drug delivery systems allow for the independent tuning of the surface chemical and physical properties that affect their biodistribution in vivo and the therapeutic payloads that they are intended to deliver. Additionally, the added therapeutic and diagnostic value of their inherent material properties often provides extra functionality. Iron based nanomaterials with their magnetic properties and easily tailorable surface chemistry are of particular interest as model systems. In this study the core radius of the iron oxide nanoparticles (NPs) was 14.08 ± 3.92 nm while the hydrodynamic radius of the NPs, as determined by Dynamic Light Scattering (DLS), was between 90-110 nm. In this study, different approaches were explored to create radiolabeled NPs that are stable in solution. The NPs were functionalized with polycarboxylate or polyamine surface functional groups. Polycarboxylate functionalized NPs had a zeta potential of -35 mV and polyamine functionalized NPs had a zeta potential of +40 mV. The polycarboxylate functionalized NPs were chosen for in vivo biodistribution studies and hence were radiolabeled with (14)C, with a final activity of 0.097 nCi mg(-1) of NPs. In chronic studies, the biodistribution profile is tracked using low level radiolabeled proxies of the nanoparticles of interest. Conventionally, these radiolabeled proxies are chemically similar but not chemically identical to the non-radiolabeled NPs of interest. This study is novel as different approaches were explored to create radiolabeled NPs that are stable, possess a hydrodynamic radius of <100 nm and most importantly they exhibit an identical surface chemical functionality as their non-radiolabeled counterparts. Identical chemical functionality of the radiolabeled probes to the non-radiolabeled probes was an important consideration to generate statistically similar biodistribution data sets using multiple imaging and detection techniques. The radiolabeling approach described here is applicable to the synthesis of a large class of nanomaterials with multiple core and surface functionalities. This work combined with the biodistribution data suggests that the radiolabeling schemes carried out in this study have broad implications for use in pharmacokinetic studies for a variety of nanomaterials.

[1]  Gaurav Kumar Jain,et al.  Metallic nanoparticles: technology overview & drug delivery applications in oncology , 2010, Expert opinion on drug delivery.

[2]  Sonu Sundd Singh,et al.  Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. , 2006, Current drug metabolism.

[3]  Prakash D Nallathamby,et al.  Design of stable and uniform single nanoparticle photonics for in vivo dynamics imaging of nanoenvironments of zebrafish embryonic fluids. , 2008, ACS nano.

[4]  Ryan Chamberlain,et al.  SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain. , 2013, Journal of Alzheimer's disease : JAD.

[5]  L. Migliore,et al.  Multiple cytotoxic and genotoxic effects induced in vitro by differently shaped copper oxide nanomaterials. , 2013, Mutagenesis.

[6]  Douglas J Taatjes,et al.  Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells. , 2007, American journal of respiratory cell and molecular biology.

[7]  Hamidreza Ghandehari,et al.  In vivo methods of nanotoxicology. , 2012, Methods in molecular biology.

[8]  Naomi K Fukagawa,et al.  Assessing nanotoxicity in cells in vitro. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[9]  Bernhard Gleich,et al.  Magnetized Aerosols Comprising Superparamagnetic Iron Oxide Nanoparticles Improve Targeted Drug and Gene Delivery to the Lung , 2012, Pharmaceutical Research.

[10]  M. Hashida,et al.  Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats. , 1999, Journal of pharmaceutical sciences.

[11]  Heidi Ledford Drug candidates derailed in case of mistaken identity , 2012, Nature.

[12]  J. Panyam,et al.  Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. , 2013, Biomaterials.

[13]  P. Nallathamby,et al.  Study of charge-dependent transport and toxicity of peptide-functionalized silver nanoparticles using zebrafish embryos and single nanoparticle plasmonic spectroscopy. , 2013, Chemical research in toxicology.

[14]  Jolyon Mitchell,et al.  In vitro and in vivo aspects of cascade impactor tests and inhaler performance: A review , 2007, AAPS PharmSciTech.

[15]  Krishnendu Roy,et al.  Micro and Nanoparticle‐Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective , 2013, Advanced healthcare materials.

[16]  Michael J Welch,et al.  Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications. , 2012, Bioconjugate chemistry.

[17]  Park,et al.  A Hyperbranched Poly(ethyleneimine) Grown on Surfaces. , 2000, Journal of colloid and interface science.

[18]  Kostas Kostarelos,et al.  Physiologically based pharmacokinetic modeling of nanoparticles. , 2010, ACS nano.

[19]  Agnes G Oomen,et al.  What do we (need to) know about the kinetic properties of nanoparticles in the body? , 2007, Regulatory toxicology and pharmacology : RTP.

[20]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[21]  Pedro M. Valencia,et al.  Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation , 2012 .

[22]  Andreas Mandelis,et al.  Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics , 2012, Biomedical optics express.

[23]  P. Nallathamby,et al.  Design and characterization of optical nanorulers of single nanoparticles using optical microscopy and spectroscopy. , 2010, Nanoscale.

[24]  D. Gillet,et al.  Design and synthesis of single-nanoparticle optical biosensors for imaging and characterization of single receptor molecules on single living cells. , 2007, Analytical chemistry.

[25]  Christian Plank,et al.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection—Progress and prospects , 2011, Advanced Drug Delivery Reviews.

[26]  Surya Singh Nanomedicine-nanoscale drugs and delivery systems. , 2010, Journal of nanoscience and nanotechnology.

[27]  F. Hefti Requirements for a lead compound to become a clinical candidate , 2008, BMC Neuroscience.

[28]  D. Grainger,et al.  A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. , 2012, Pharmacology & therapeutics.

[29]  Adam H Love,et al.  Quantitating isotopic molecular labels with accelerator mass spectrometry. , 2005, Methods in enzymology.

[30]  J. Ryczkowski FT-IR study of the adsorption of some complexones and of EDTA alkaline salts into alumina , 2000 .

[31]  Meng Wang,et al.  Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  C. Alden,et al.  Predictive Toxicology Approaches for Small Molecule Oncology Drugs , 2010, Toxicologic pathology.

[33]  Jolyon Mitchell,et al.  Analysis of cascade impactor mass distributions. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[34]  Samir Mitragotri,et al.  Multifunctional nanoparticles for drug delivery and molecular imaging. , 2013, Annual review of biomedical engineering.

[35]  W. Choi,et al.  Charge-transfer surface complex of EDTA-TiO2 and its effect on photocatalysis under visible light , 2010 .

[36]  P. Nallathamby,et al.  Study of cytotoxic and therapeutic effects of stable and purified silver nanoparticles on tumor cells. , 2010, Nanoscale.

[37]  Jason S. Lewis,et al.  H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu. , 2012, Inorganic chemistry.

[38]  S. Retterer,et al.  Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. , 2013, Nanoscale.

[39]  Forrest M Kievit,et al.  Surface engineering of iron oxide nanoparticles for targeted cancer therapy. , 2011, Accounts of chemical research.

[40]  P. Russell,et al.  Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? , 2010, Stem cells.

[41]  J. Cheon,et al.  Theranostic magnetic nanoparticles. , 2011, Accounts of chemical research.

[42]  P. Reddanna,et al.  Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: Role of ROS-NFκB signaling pathway , 2011, Nanotoxicology.

[43]  Satish K. Nune,et al.  Nanoparticles for biomedical imaging , 2009, Expert opinion on drug delivery.

[44]  Hao Hong,et al.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.

[45]  P. Bartenstein,et al.  Click-chemistry reactions in radiopharmaceutical chemistry: fast & easy introduction of radiolabels into biomolecules for in vivo imaging. , 2010, Current medicinal chemistry.

[46]  Kai Qi,et al.  64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[47]  M. Muhammed,et al.  Superparamagnetism of magnetite nanoparticles: dependence on surface modification. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[48]  J D Slack,et al.  Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration. , 1981, Journal of pharmaceutical sciences.

[49]  J. Mckim Building a Tiered Approach to In Vitro Predictive Toxicity Screening: A Focus on Assays with In Vivo Relevance , 2010, Combinatorial chemistry & high throughput screening.

[50]  K. Turteltaub,et al.  Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry. , 2012, Nano letters.

[51]  P. Choyke,et al.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.

[52]  Katya Tsaioun,et al.  De-Risking Drug Discovery with ADDME — Avoiding Drug Development Mistakes Early , 2009, Alternatives to laboratory animals : ATLA.

[53]  F. Guengerich,et al.  Mechanisms of drug toxicity and relevance to pharmaceutical development. , 2011, Drug metabolism and pharmacokinetics.

[54]  C. Mamat,et al.  Cross‐Coupling Reactions as Valuable Tool for the Preparation of PET Radiotracers , 2011 .

[55]  Wei Gao,et al.  Nano/Microscale motors: biomedical opportunities and challenges. , 2012, ACS nano.

[56]  J. Ludvigsson,et al.  Thinner needles do not influence injection pain, insulin leakage or bleeding in children and adolescents with type 1 diabetes , 2000, Pediatric diabetes.

[57]  P Blardi,et al.  A short introduction to pharmacokinetics. , 2002, European review for medical and pharmacological sciences.

[58]  A. S. Moses,et al.  Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.